Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-907
Closed -$165K 811
2022
Q1
$165K Buy
+907
New +$203K 0.05% 382
2021
Q4
Sell
-1,143
Closed -$234K 887
2021
Q3
$234K Buy
1,143
+112
+11% +$23.5K 0.06% 354
2021
Q2
$189K Buy
1,031
+1,027
+25,675% +$213K 0.04% 420
2021
Q1
$838 Hold
4
﹤0.01% 750
2020
Q4
$736 Hold
4
﹤0.01% 702
2020
Q3
$683 Hold
4
﹤0.01% 654
2020
Q2
$455 Hold
4
﹤0.01% 619
2020
Q1
$287 Hold
4
﹤0.01% 641
2019
Q4
$437 Hold
4
﹤0.01% 623
2019
Q3
$386 Hold
4
﹤0.01% 602
2019
Q2
$331 Hold
4
﹤0.01% 617
2019
Q1
$259 Hold
4
﹤0.01% 563
2018
Q4
$180 Hold
4
﹤0.01% 631
2018
Q3
$230 Hold
4
﹤0.01% 594
2018
Q2
$315 Hold
4
﹤0.01% 582
2018
Q1
$305 Hold
4
﹤0.01% 526
2017
Q4
$303 Hold
4
﹤0.01% 517
2017
Q3
$261 Hold
4
﹤0.01% 484
2017
Q2
$212 Hold
4
﹤0.01% 535
2017
Q1
$188 Hold
4
﹤0.01% 462
2016
Q4
$142 Hold
4
﹤0.01% 524
2016
Q3
$133 Hold
4
﹤0.01% 524
2016
Q2
$145 Hold
4
﹤0.01% 457
2016
Q1
$119 Hold
4
﹤0.01% 520
2015
Q4
$123 Hold
4
﹤0.01% 448
2015
Q3
$124 Buy
+4
New +$124 ﹤0.01% 485

Other funds holding BLD

Exane Derivatives's BLD Position: Q2 2022 in Review

Exane Derivatives sold out of TopBuild (BLD) in Q2 2022, closing a stake of 907 shares — an estimated $165K sold.

Exane Derivatives first reported a position in BLD in Q3 2015 and held it in 26 quarters. The position peaked at $234K in Q3 2021. 349 funds tracked by Wall St. Rank hold BLD as of Q2 2022.

  • Exane Derivatives reported no remaining TopBuild position as of Q2 2022 after selling out during the quarter.
  • Exane Derivatives sold 907 TopBuild shares in Q2 2022, an estimated $165K.
  • Exane Derivatives first reported a position in TopBuild in Q3 2015 and held it in 26 quarters.
  • Exane Derivatives's TopBuild position peaked at $234K in Q3 2021.
  • 349 funds tracked by Wall St. Rank held TopBuild as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.